Viewing Study NCT00344799



Ignite Creation Date: 2024-05-05 @ 4:54 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00344799
Status: COMPLETED
Last Update Posted: 2021-03-29
First Post: 2006-06-26

Brief Title: Cytogenetic Study of Ocular Melanoma
Sponsor: Jonsson Comprehensive Cancer Center
Organization: Jonsson Comprehensive Cancer Center

Study Overview

Official Title: Molecular and Cytogenetic Studies of Ocular Melanoma
Status: COMPLETED
Status Verified Date: 2021-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients who are diagnosed with choroidal melanoma and undergo I-125 plaque or enucleation surgery consent to participate in the study A tumor sample taken during surgery is studied in the lab for genetic features These features and features of subjects clinical course are recorded Analysis of the data may identify genetic features that are indicative of prognostic factors including risk of metastasis
Detailed Description: The Jules Stein Eye Institute Ocular Melanoma Research Group is conducting cytogenetic studies of choroidal melanoma to improve the screening of biopsy samples of choroidal melanoma through cytogenetic analysis Our goal is to identify molecular probes that specifically target regions of chromosomes that undergo changes characteristic of metastatic choroidal melanoma

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
11-000847 OTHER University of California at Los Angeles None